93 - HIV Treatment in the Real World

Moderator(s)

• 

  Maximo Brito, MD, MPH (he/him/his)

  Professor of Medicine
  University of Illinois at Chicago
  Chicago, IL, United States
• 

  Elizabeth Sherman, PharmD

  Associate Professor
  Division of Infectious Disease
  Nova Southeastern University
  Fort Lauderdale, FL, United States

Presentations:

• 3:15 PM – 3:27 PM US ET

  Suppressed Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide vs. Dolutegravir/Lamivudine: Virologic Failure and Durability
  

  Presenting Author: Gerald Pierone, Jr., MD (he/him/his) – Whole Family Health Center

  Co-Author: Jennifer S. Fusco, BS – Epividian, Inc.

  Co-Author: Laurence Brunet, PhD – Epividian, Inc.

  Co-Author: Michael Sension, MD (he/him/his) – CAN Community Health

  Co-Author: Megan Dunbar, PhD (she/her/hers) – Gilead Sciences

  Co-Author: Joshua Gruber, PhD – Gilead Sciences

  Co-Author: Douglas Dieterich, MD – Mount Sinai Healthcare System

  Co-Author: Gregory P. Fusco, MD, MPH – Epividian, Inc.
• 3:27 PM – 3:39 PM US ET

  Real-world Adherence and Persistence with Long-Acting Cabotegravir Plus Rilpivirine (CAB+RPV LA) Compared to Oral Antiretroviral Therapy (ART) Among People with HIV (PWH) in the US: The ABOVE Study
  

  Presenting Author: Cindy Garris, MS (she/her/hers) – ViiV Healthcare

  Co-Author: Raj Desai, PhD – Analysis Group, Inc.

  Co-Author: Rose Chang, ScD – Analysis Group, Inc.

  Co-Author: Louise Clear, MPH – Analysis Group, Inc.

  Co-Author: Zhuo Chen, MPH – Analysis Group, Inc.

  Co-Author: Daisy Liu, MS – Analysis Group, Inc.

  Co-Author: Maral DerSarkissian, PhD – Analysis Group, Inc.

  Co-Author: Paula Teichner, PharmD – ViiV Healthcare

  Co-Author: Edgar T. Overton, MD – ViiV Healthcare
• 3:39 PM – 3:51 PM US ET

  Consequences of Low-level Viremia Among Women with HIV in the United States
  

  Presenting Author: Amalia Aldredge, MD (she/her/hers) – Emory University

  Co-Author: Cyra Christina Mehta, PhD, MSPH – Emory University School of Medicine

  Co-Author: Lauren F. Collins, MD, MSc (she/her/hers) – Emory University School of Medicine, Division of Infectious Diseases

  Co-Author: Cecile D. Lahiri, MD, MS (she/her/hers) – Emory University

  Co-Author: Maria L. Alcaide, MD – Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine

  Co-Author: Jack DeHovitz, MD, MPH – State University of New York-Downstate Medical Center

  Co-Author: Kathryn Anastos, MD – Department of Medicine, Albert Einstein College of Medicine, Bronx, New York

  Co-Author: Michael Plankey, PhD – Georgetown University

  Co-Author: Jodie A. Dionne, MD, MSPH (she/her/hers) – University of Alabama at Birmingham

  Co-Author: Michelle Floris-Moore

  Co-Author: Michael F. Schneider, MSc – Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health

  Co-Author: Audrey L. French, MD – Stroger Hospital of Cook County

  Co-Author: Phyllis C. Tien, MD, MSc – Division of Infectious Diseases, Department of Medicine, University of California, San Francisco, San Francisco, California and Medical Service, Department of Veterans Affairs, San Francisco, California

  Co-Author: Anandi N. Sheth, MD, MSc – Emory University School of Medicine
• 3:51 PM – 4:03 PM US ET

  Hepatitis B Reactivation in Persons with HIV with Positive Hepatitis B Core Antibody after Switching to Antiretroviral Therapy without Hepatitis B Activity
  

  Presenting Author: Rachel V. Denyer, MD MRCP – Washington DC VA Medical Center/ George Washington University

  Co-Author: Janet P. Tate, MPH ScD – VA Connecticut Healthcare System/ Yale University School of Medicine

  Co-Author: Debra A. Benator, MD – Washington DC VA Medical Center

  Co-Author: Joseph K. Lim, MD – Yale University School of Medicine

  Co-Author: Amy Weintrob, MD – Washington DC VA Medical Center/ George Washington University
• 4:03 PM – 4:15 PM US ET

  At-Home vs. In-Clinic Receipt of Cabotegravir and Rilpivirine Long-Acting: An Implementation Science Trial
  

  Co-Author: Jamila K. Williams, MHA – Medical University of South Carolina

  Co-Author: Christina Young, LPN – Medical University of South Carolina

  Co-Author: Rochelle F. Hanson, Ph.D. – Medical University of South Carolina

  Co-Author: Angela Moreland-Johnson, Ph.D. – Medical University of South Carolina

  Co-Author: Ruth O. Adekunle, MD, MSCR – Medical University of South Carolina

  Co-Author: Stephanie Kirk, PharmD – Medical University of South Carolina

  Presenting Author: Eric G. Meissner, MD, PhD – Medical University of South Carolina
• 4:15 PM – 4:27 PM US ET

  Real-World Use of Long-Acting Cabotegravir + Rilpivirine in People with HIV with Detectable Viral Loads at Initiation: Findings from the OPERA^® Cohort
  

  Presenting Author: Ricky K. Hsu, MD (he/him/his) – AIDS Healthcare Foundation/ NYU School of Medicine

  Co-Author: Michael Sension, MD (he/him/his) – CAN Community Health

  Co-Author: Jennifer S. Fusco, BS – Epividian, Inc.

  Co-Author: Laurence Brunet, PhD – Epividian, Inc.

  Co-Author: Quateka Cochran, Masters of Nursing – Aids Healthcare Foundation

  Co-Author: Gayathri Sridhar, MBBS, MPH, PhD – ViiV Healthcare

  Co-Author: Vani Vannappagari, MBBS, MPH, PhD – ViiV Healthcare

  Co-Author: Jean A. van Wyk, MBChB, MFPM – ViiV Healthcare, Brentford, UK

  Co-Author: Michael B. Wohlfeiler, JD, MD, AAHIVS – AIDS Healthcare Foundation

  Co-Author: Gregory P. Fusco, MD, MPH – Epividian, Inc.